M&A Deal Summary |
|
|---|---|
| Date | 2024-04-24 |
| Target | Cidara Therapeutics - REZZAYO |
| Sector | Life Science |
| Buyer(s) | Mundipharma |
| Sellers(s) | Cidara Therapeutics |
| Deal Type | Divestiture |
SEARCH BY
Try For Free 7-Day Free Trial
Mundipharma is a global network of privately-owned independent associated companies and now operates in over 120 countries worldwide. The company is focused on developing business partnerships to identify and accelerate meaningful technology across an increasingly diverse portfolio of therapy areas including respiratory, oncology, pain, and biosimilars. Mundipharma was founded in 1952 and is based in Cambridge, United Kingdom.
| DEAL STATS | # |
|---|---|
| Overall | 2 of 2 |
| Sector (Life Science) | 2 of 2 |
| Type (Divestiture) | 2 of 2 |
| State (California) | 1 of 1 |
| Country (United States) | 1 of 1 |
| Year (2024) | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2018-10-10 |
Cinfa Biotech S.L.
Olloki, Spain Cinfa Biotech S.L. is a developer, manufacturer of high-quality biosimilars for oncology and inflammatory diseases. Cinfa Biotech was formed in 2013 and is based in Olloki, Spain. |
Buy | - |
| Category | Company |
|---|---|
| Founded | 2012 |
| Sector | Life Science |
| Employees | 73 |
| Revenue | 64M USD (2022) |
Cidara Therapeutics is a biotechnology company focused on the discovery, development, and commercialization of novel anti-infectives. Cidara Therapeutics was founded in 2012 and is headquartered in San Diego, California.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector (Life Science) | 1 of 1 |
| Type (Divestiture) | 1 of 1 |
| State (California) | 1 of 1 |
| Country (United States) | 1 of 1 |
| Year (2024) | 1 of 1 |
